Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Cytokine profile in relapsing‑remitting multiple sclerosis patients and the association between progression and activity of the disease.
Genzyme receives Complete Response Letter from FDA on Lemtrada™ (alemtuzumab) application
MARGA: Multispectral Adaptive Region Growing Algorithm for brain extraction on axial MRI.
Multiple sclerosis: Does aggressive MS warrant aggressive treatment?
Plasma exchange in severe attacks of neuromyelitis optica.
Biologics at Novartis
[Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a german high-volume clinic].
Two discreet subsets of CD8 T cells modulate PLP(91-110) induced experimental autoimmune encephalomyelitis in HLA-DR3 transgenic mice.
Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: An open-label study.
Influence of pregnancy on neuromyelitis optica spectrum disorder.
Phase 2 results of the RADIANCE trial: a randomized, double-blind, placebo-controlled trial of oral RPC1063 in relapsing multiple sclerosis
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Subclinical CNS Inflammation as Response to a Myelin Antigen in Humanized Mice.
Genome-wide association study of multiple sclerosis confirms a novel locus at 5p13.1.
COMPARE: pharmacokinetic profiles of subcutaneous peginterferon beta-1a and subcutaneous interferon beta-1a over 2 weeks in healthy subjects.
Multiple sclerosis: Spinal cord grey matter loss correlates with disability in MS.
Astrocytes Underlie Neuroinflammatory Memory Impairment.
Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Biochemical Markers of Autoimmune Diseases of the Nervous System.
Amelioration of experimental autoimmune encephalomyelitis by probiotic mixture is mediated by a shift in T helper cell immune response.
Disease-modifying therapies in Chinese children with multiple sclerosis.
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
Simvastatin shows promise in treating progressive multiple sclerosis, study finds.
Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.

Pages